Literature DB >> 27203143

Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis.

Bradley A Gross1, Rose Du2.   

Abstract

OBJECTIVE The aim of this paper is to define an overall cavernous malformation (CM) hemorrhage rate and risk factors for hemorrhage. METHODS The authors performed a systematic, pooled analysis via the PubMed database through October 2015 using the terms "cavernoma," "cavernous malformation," "natural history," "bleeding," and "hemorrhage." English-language studies providing annual rates and/or risk factors for CM hemorrhage were included. Data extraction, performed independently by the authors, included demographic data, hemorrhage rates, and hemorrhage risk factors. RESULTS Across 12 natural history studies with 1610 patients, the mean age at presentation was 42.7 years old and 52% of patients (95% CI 49%-55%) were female. Presentation modality was seizure in 30% (95% CI 25%-35%), hemorrhage in 26% (95% CI 17%-37%), incidental in 17% (95% CI 9%-31%), and focal deficits only in 16% of cases (95% CI 11%-23%). CM location was lobar in 66% (95% CI 61%-70%), brainstem in 18% (95% CI 13%-24%), deep supratentorial in 8% (95% CI 6%-10%), and cerebellar in 8% (95% CI 5%-11%). Pooling 7 studies that did not assume CM presence since birth, the annual hemorrhage rate was 2.5% per patient-year over 5081.2 patient-years of follow-up (95% CI 1.3%-5.1%). Pooling hazard ratios across 5 studies that evaluated hemorrhage risk factors, prior CM hemorrhage was a significant risk factor for hemorrhage (HR 3.73, 95% CI 1.26-11.1; p = 0.02) while younger age, female sex, deep location, size, multiplicity, and associated developmental venous anomalies (DVAs) were not. CONCLUSIONS Although limited by the heterogeneity of incorporated reports and selection bias, this study found prior hemorrhage to be a significant risk factor for CM bleeding, while age, sex, CM location, size, multiplicity, and associated DVAs were not. Future natural history studies should compound annual hemorrhage rate with prospective seizure and nonhemorrhagic neurological deficit rates.

Entities:  

Keywords:  CM = cavernous malformation; DVA = developmental venous anomaly; bleed; cavernoma; cavernous hemangioma; cavernous malformation; epidemiology; hemorrhage; natural history; vascular disorders

Mesh:

Year:  2016        PMID: 27203143     DOI: 10.3171/2016.3.JNS152419

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

Review 1.  Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling.

Authors:  Stefanie Spiegler; Matthias Rath; Christin Paperlein; Ute Felbor
Journal:  Mol Syndromol       Date:  2018-01-25

Review 2.  Clinical Management of Cavernous Malformations.

Authors:  Kelly D Flemming
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

3.  Subarachnoid Hemorrhage due to Cerebral Cavernous Malformation in a Young Female.

Authors:  Cleopatra Thurman; Kasim Qureshi; Baljit Deol; Muhammad U Farooq
Journal:  Neurohospitalist       Date:  2022-06-30

4.  Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort.

Authors:  Lu Kong; Xiu-Jian Ma; Xiao-Ying Xu; Pan-Pan Liu; Ze-Yu Wu; Li-Wei Zhang; Jun-Ting Zhang; Zhen Wu; Liang Wang; Da Li
Journal:  Neurosurg Rev       Date:  2022-05-28       Impact factor: 2.800

Review 5.  Presentation and management of nervous system cavernous malformations in children: A systematic review and case report.

Authors:  Uma V Mahajan; Mohit Patel; Jonathan Pace; Brian D Rothstein
Journal:  Brain Circ       Date:  2022-09-21

6.  Surgical management of simultaneous supra- and infratentorial hemorrhages in a pediatric patient with multiple cavernomas.

Authors:  Gaurav Tyagi; Abhay Sikaria; Gyani Jail Singh Birua; Manish Beniwal; Dwarakanath Srinivas
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2022-02-28

7.  Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.

Authors:  Miguel Alejandro Lopez-Ramirez; Angela Pham; Romuald Girard; Tine Wyseure; Preston Hale; Atsuki Yamashita; Janne Koskimäki; Sean Polster; Laleh Saadat; Ignacio A Romero; Charles T Esmon; Frederic Lagarrigue; Issam A Awad; Laurent O Mosnier; Mark H Ginsberg
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

8.  Natural history of incidentally diagnosed brainstem cavernous malformations in a prospective observational cohort.

Authors:  Jing-Jie Zheng; Pan-Pan Liu; Liang Wang; Li-Wei Zhang; Jun-Ting Zhang; Da Li; Zhen Wu; Yu-Mei Wu
Journal:  Neurosurg Rev       Date:  2020-05-12       Impact factor: 3.042

9.  Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.

Authors:  Julián Carrión-Penagos; Hussein A Zeineddine; Sean P Polster; Romuald Girard; Seán B Lyne; Janne Koskimäki; Sharbel Romanos; Abhinav Srinath; Dongdong Zhang; Ying Cao; Agnieszka Stadnik; Kristina Piedad; Robert Shenkar; Issam A Awad
Journal:  J Neurosurg       Date:  2020-04-03       Impact factor: 5.115

Review 10.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.